Diamyd Logo
This website is only intended for investors

Diamyd Medical − Curing diabetes

Diamyd develops pharmaceuticals for the treatment of autoimmune diabetes and its complications. Our vision is to one day be able to prevent and cure the autoimmune form of diabetes. Diamyd's lead product, the diabetes vaccine Diamyd® has shown to significantly slow down the disease process.
Get Flash Player

Diabetes − a chronic disease
Diabetes is associated with serious complications due to elevated and fluctuating blood sugar levels, resulting in considerable suffering and extensive costs for society.

Trials with the Diamyd® vaccine
Diamyd Medical is currently enrolling patients with recent onset type 1 diabetes in two ongoing Phase III clinical trials. One in the US and one in Europe.